Management of adult patients with severe atopic dermatitis treated with dupilumab duringCOVID-19 pandemic: A single-center real-life experience

被引：16
|
作者：
Rossi, Mariateresa [1 ]
Rovati, Chiara [1 ]
Arisi, Mariachiara [1 ]
Soglia, Simone [1 ]
Calzavara-Pinton, Piergiacomo [1 ]
机构：
[1] Univ Brescia, Dermatol Dept, ASST Spedali Civili Brescia, Brescia, Italy
来源：
DERMATOLOGIC THERAPY | 2020年 / 33卷 / 04期
关键词：
D O I：
10.1111/dth.13765
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease
    Elizabeth A. Spencer
    Michael T. Dolinger
    Marla C. Dubinsky
    Digestive Diseases and Sciences, 2023, 68 : 1121 - 1124
  • [22] Real-life practice: rapid improvement in itch symptomatology in patients with atopic dermatitis treated with dupilumab
    Pistone, Giuseppe
    Tilotta, Giovanna
    Gurreri, Rosario
    Castelli, Elena
    Curiale, Salvatrice
    Bongiorno, Maria Rita
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (01) : 127 - 127
  • [23] Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study
    De Greef, Axel
    Ghislain, Pierre-Dominique
    Bulinckx, Audrey
    Coster, Alison
    de Halleux, Celine
    Damsin, Thomas
    Jacobs, Marie-Claude
    Suys, Erwin
    Zoghaib, Samer
    Baeck, Marie
    CLINICAL DRUG INVESTIGATION, 2023, 43 (04) : 299 - 306
  • [24] Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study
    Axel De Greef
    Pierre-Dominique Ghislain
    Audrey Bulinckx
    Alison Coster
    Céline de Halleux
    Thomas Damsin
    Marie-Claude Jacobs
    Erwin Suys
    Samer Zoghaib
    Marie Baeck
    Clinical Drug Investigation, 2023, 43 : 299 - 306
  • [25] Laboratory markers of dupilumab patients with moderate-to-severe atopic dermatitis: a single-center, real-world study
    Hawkins, K.
    Sharma, D.
    Shokrian, N.
    Piontkowski, A.
    Ungar, B.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S162 - S162
  • [26] Real-life management of atopic dermatitis patients with an inadequate response to on-label use of dupilumab
    Strizzolo, Remi
    Seneschal, Julien
    Soria, Angele
    Staumont-Salle, Delphine
    Barbarot, Sebastien
    Viguier, Manuelle
    Jachiet, Marie
    Nosbaum, Audrey
    Clement, Aude
    Tauber, Marie
    Mallet, Stephanie
    Du-Thanh, Aurelie
    WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (07):
  • [27] REAL-LIFE EXPERIENCE IN THE EFFECTIVENESS , IMPACT ON QUALITY OF LIFE AND SAFETY OF DUPILUMAB TREATMENT IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS IN THE CZECH REPUBLIC
    Tanczosova, Milena
    Kojanova, Martina
    Arenbergerova, Monika
    Arenberger, Petr
    Dolezal, Tomas
    Strosova, Daniela
    Fialova, Jorga
    Gkalpakiotis, Spyridon
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 30 (01) : 46 - 50
  • [28] Dupilumab for severe atopic dermatitis - real life experience in a portuguese tertiary centre
    Bras, R.
    Lopes, A.
    Neto, M.
    Spinola-Santos, A.
    Mendes, A.
    Costa, C.
    Pedro, E.
    Pereira-Barbosa, M.
    ALLERGY, 2020, 75 : 450 - 450
  • [29] Treatment of children from 6 to 11 years old affected by moderate-severe atopic dermatitis with dupilumab: a first perspective from a single-center real-life experience in Italy
    Colonna, C.
    Zussino, M.
    Monzani, N. A.
    Ponziani, A.
    Cavalli, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (06) : E478 - E480
  • [30] Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients
    Turk, Murat
    Bahcecioglu, Sakine Nazik
    Tutar, Nuri
    Oymak, Fatma Sema
    Gulmez, Inci
    Yilmaz, Insu
    TURKISH THORACIC JOURNAL, 2018, 19 (04) : 187 - 192
12345